SEARCH

SEARCH BY CITATION

References

  • 1
    Lawson DH. Pharmacovigilance in the 1990s. Br J Clin Pharmacol 1997; 44: 109110.
  • 2
    Impicciatore P, Pandolfini C, Bosetti C, Bonati M. Adverse drug reactions in children: a systematic review of published case reports. Pediatr Perinat Drug Ther 1998; 2: 2736.
  • 3
    Bonati M, Marchetti F, Zullini MT, Pistotti V, Tognoni G. Adverse drug reactions in neonatal intensive care units. Adverse Drug Reactions Poisoning Rev 1990; 9: 103118.
  • 4
    Impicciatore P & Choonara I. Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use. Br J Clin Pharmacol 1999; 48: 1518.DOI: 10.1046/j.1365-2125.1999.00981.x
  • 5
    Conroy S, Choonara I, Impicciatore P, et al. Unlicensed and off-label durg use in paediatric wards in different European countries. Br Med J 2000; 320: 7982.
  • 6
    Bonati M, Impicciatore P, Pandolfini C. The registry of clinical trials in children must be set up. Br Med J 2000; 320: 13391340.
  • 7
    Conroy S, McIntyre J, Choonara I, Stephenson T. Drug trials in children: problems and the way forward. Br J Clin Pharmacol 2000; 49: 9397.DOI: 10.1046/j.1365-2125.2000.00125.x
  • 8
    Temple R. Meta-analysis and epidemiologic studies in drug development and post marketing surveillance. JAMA 1999; 281: 841844.
  • 9
    Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998; 279: 12001205.
  • 10
    Bonati M, Choonara I, Hoppu K, Pons G, Seyberth H. Closing the gap in drug therapy. Lancet 1999; 355: 1625.
  • 11
    Greenland S. Meta-analysis. In Modern Epidemiology eds Rothman KJ, Greenland S. Philadelphia; Lippincott Raven Publishers, 1998: pp 643675.
  • 12
    Berkey CS, Hoaglin DC, Mosteller F, Colditz GA. A random-effects regression model for meta-analysis. Stat Med 1995; 14: 395411.
  • 13
    Collins GE, Clay MM, Falletta JM. A prospective study of the epidemiology of adverse drug reactions in pediatric hematology and oncology patients. Am J Hosp Pharm 1974; 31: 968975.
  • 14
    Kramer MS, Hutchinson TA, Flegel KM, Naimark L, Contardi R, Leduc DG. Adverse drug reactions in general pediatric outpatients. J Pediatr 1976; 89: 487490.
  • 15
    Woods CG, Rylance ME, Cullen RE, Rylance GW. Adverse reactions to drugs in children. Br Med J 1987; 294: 869870.
  • 16
    Dharnidharka VR, Kandoth P, Anand RK. Adverse drug reactions in pediatrics with a study of in-hospital intensive surveillance. Indian Pediatr 1993; 30: 745751.
  • 17
    McKenzie MW, Stewart RB, Weiss CF, Cluff LE. A pharmacist based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 1973; 30: 898903.
  • 18
    Whyte J & Greenan E. Drug usage and adverse drug reactions in paediatric patients. Acta Paediatr Scand 1977; 66: 767775.
  • 19
    Mitchell AA, Goldman P, Shapiro S, Slone D. Drug utilisation and reported adverse reactions in hospitalised children. Am J Epidemiol 1979; 110: 196204.
  • 20
    Choonara IA & Harris F. Adverse reactions in medical inpatients. Arch Dis Child 1984; 59: 578580.
  • 21
    Vazques de la Villa A, Luna del Castillo JD, Galdo-Munoz G, Puche-Canas E. Reacciones adversas causadas por medicamentos en Pediatria. An Esp Pediatr 1989; 31: 4953.
  • 22
    Gill AM, Leach HJ, Hughes J, Barker C, Nunn AJ, Choonara I. Adverse drug reactions in a paediatric intensive care unit. Acta Paediatrica 1995; 84: 438441.
  • 23
    Gonzales-Martin G, Caroca CM, Paris E. Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study. Int J Clin Pharm Ther 1998; 36: 530533.
  • 24
    Turner S, Nunn AJ, Fielding K, Choonara I. Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatrica 1999; 88: 965968.DOI: 10.1080/08035259950168469
  • 25
    Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer JM, Rubio E, Morales-Olivas FJ. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999; 47: 681688.DOI: 10.1046/j.1365-2125.1999.00943.x
  • 26
    McKenzie MW, Marchall GL, Netzloff ML, Cluff LE. Adverse drug reactions leading to hospitalization in children. J Pediatr 1976; 89: 487490.
  • 27
    Yosselson-Supertimes G & Weiss T. Drug related hospitalization in pediatric patients. J Clin Hosp Pharm 1982; 713: 195.
  • 28
    Mitchell AA, Lacoutre PG, Sheehan JE, Kauffman RE, Shapiro S. Adverse drug reactions in children leading to hospital admission. Pediatrics 1988; 82: 2429.
  • 29
    Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol 1996; 42: 319324.
  • 30
    Easton KL, Parsons BJ, Starr M, Brien J. The incidence of drug-related problems as a cause of hospital admissions in children. Med J Austr 1998; 169: 356359.
  • 31
    Sanz E & Boada J. Adverse drug reactions in pediatric outpatients. Int J Clin Pharm Res 1987; 7: 169172.
  • 32
    Cirko-Begovic A, Vrhovac B, Bakran I. Intensive monitoring of adverse drug reactions in infants and preschool children. Eur J Clin Pharmacol 1989; 36: 6365.
  • 33
    Menniti-Ippolito F, Raschetti R, Da Cas R, Giaquinto C, Cantarutti L. Active monitoring of adverse drug reactions in children. Lancet 2000; 355: 16131614.DOI: 10.1016/s0140-6736(00)02219-4
  • 34
    Einarson T. Drug related hospital admissions. Ann Pharmacother 1993; 27: 832840.
  • 35
    Fattinger K, Roos M, Vergeres P, et al. Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol 2000; 49: 158167.DOI: 10.1046/j.1365-2125.2000.00132.x
  • 36
    Bates DW, Miller EB, Cullen DJ, et al. Patient risk factors for adverse drug events in hospitalized patients. Arch Intern Med 1999; 159: 25532560.
  • 37
    Choonara I, Gill A, Nunn A. Drug toxicity and surveillance in children. Br J Clin Pharmacol 1996; 42: 407410.
  • 38
    Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admission to hospital caused by adverse drug reactions: cross sectional incidence study. Br Med J 2000; 320: 1036.
  • 39
    Collier J. Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indications. Br J Clin Pharmacol 1999; 48: 58.DOI: 10.1046/j.1365-2125.1999.00983.x
  • 40
    Bonati M. Epidemiological evaluation of drug use in children. J Clin Pharmacol 1994; 34: 300305.
  • 41
    McAuley L, Pham B, Tugwell P, Moher D. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet 2000; 356: 12281231.
  • 42
    Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. Br Med J 1996; 313: 570571.
  • 43
    Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. A proposal for reporting. JAMA 2000; 283: 20082012.